e-learning
resources
Vienna 2009
Monday, 14.09.2009
Treatment and prevention of lower respiratory tract infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The emerging problem of treating pulmonary
M. avium complex
(MAC) disease – microbial substitution of MAC to
M. abscessus
,
Scedosporium
and
Nocardia
after multi-drug chemotherapy in pulmonary MAC disease
M. Matsuyama, A. Moriya, K. Shimizu, N. Kokuho, Y. Miura, S. Otsuka, T. Kiwamoto, K. Hayashihara, T. Saito (Nakagun Tokai-mura, Japan)
Source:
Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections
Session:
Treatment and prevention of lower respiratory tract infections
Session type:
Thematic Poster Session
Number:
2439
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Matsuyama, A. Moriya, K. Shimizu, N. Kokuho, Y. Miura, S. Otsuka, T. Kiwamoto, K. Hayashihara, T. Saito (Nakagun Tokai-mura, Japan). The emerging problem of treating pulmonary
M. avium complex
(MAC) disease – microbial substitution of MAC to
M. abscessus
,
Scedosporium
and
Nocardia
after multi-drug chemotherapy in pulmonary MAC disease. Eur Respir J 2009; 34: Suppl. 53, 2439
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
A 62-year-old man with scanty mucoid sputum
Eosinophilic COPD
Related content which might interest you:
Therapeutic outcomes for cavitary
Mycobacterium avium
complex (MAC) lung disease
Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections
Year: 2012
Pulmonary tuberculosis – Still a challenging diagnosis
Source: Annual Congress 2011 - Clinical tuberculosis
Year: 2011
Pulmonary tuberculosis presentation – Late diagnosis, advanced disease
Source: Annual Congress 2012 - Tuberculosis: clinical findings III
Year: 2012
The specificity of a new skin test – Diaskintest (recombinant protein CFP10-ESAT6) in patients with sarcoidosis and non-tuberculous pulmonary diseases
Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond
Year: 2011
Outcome of zinc & vit-A supplementation in the treatment
multidrug resistance
pulmonary tuberculosis patients
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010
Interrelation between
mTB
multi drug-resistance and cytokine activity in pulmonary TB patients and
mTB
virulence
Source: Annual Congress 2009 - Clinical immunology of tuberculosis
Year: 2009
Assessment of molecular assays for detection of MDR
Mycobacterium tuberculosis
resistant to second-line injectable drugs
Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis
Year: 2012
Primary resistance (PR) of mycobacterium tuberculosis (MBT) to antimicrobial drugs (AMBD) in patients (P) with destructive pulmonary tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 655s
Year: 2004
Regional reference centre for multi-drug resistant tuberculosis – 11 months of activity
Source: Annual Congress 2010 - Emerging drug resistance in tuberculosis
Year: 2010
Unexpectedly high incidence of pneumothorax in patients with pulmonary
Mycobacterium avium
complex infection
Source: Annual Congress 2012 - Management of severe respiratory infections
Year: 2012
LungPoint® – A new approach to peripheral lung lesions
Source: Annual Congress 2010 - Tissue is mostly the issue: diagnostic and therapeutic bronchoscopy
Year: 2010
Patients‘, relatives‘ and practitioners‘ views on pulmonary arterial hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models
Year: 2012
Prevalence and treatment outcome of drug resistant pulmonary tuberculosis in HIV negative cases – experience from a tuberculosis treatment center in India
Source: Annual Congress 2009 - Multi/extensively-drug resistant tuberculosis
Year: 2009
Helicobacter pylori
infection in COPD
Source: Annual Congress 2010 - Various aspects of respiratory epidemiology
Year: 2010
Isolation of
M. abscessus
from patients with
M. avium
complex (MAC) lung disease
Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Year: 2013
Destroyed lung secondary to tuberculosis – Surgical options
Source: Annual Congress 2012 - Surgery for infections and congenital diseases
Year: 2012
Accompanying therapy of patients with extensive drug-resistant (xdr) lung tuberculosis
Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis
Year: 2018
Airway resistances: R
aw
, sR
aw
, sR
eff
– Which is the best determinant of airway function?
Source: Annual Congress 2010 - Lung function from infancy to adulthood
Year: 2010
Evaluation of pulmonary diffusion: TL
CO
or K
CO
?
Source: Annual Congress 2010 - Advances in lung function I
Year: 2010
T spot TB reactivity – ²to treat or not to treat²
Source: Annual Congress 2009 - Clinical immunology of tuberculosis
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept